Blending talents for innovation: Team composition for cross-border R&D collaboration within multinational corporations
Eunkwang Seo (),
Hyo Kang () and
Jaeyong Song ()
Additional contact information
Eunkwang Seo: University of Illinois at Urbana-Champaign
Hyo Kang: University of Southern California
Jaeyong Song: Seoul National University
Journal of International Business Studies, 2020, vol. 51, issue 5, No 8, 885 pages
Abstract:
Abstract Despite the upsurge in cross-border R&D collaboration within multinational corporations (MNCs), firms often fail to realize the full potential of cross-border R&D teams. We examine under what conditions geographic diversity might lead to higher or lower innovation performance by focusing on the moderating roles of team composition. We first demonstrate that the geographic diversity of an MNC’s research team has a curvilinear (inverted U-shaped) relationship with the team’s innovation performance. Building upon group learning theory, we further claim that this non-linear relationship is strengthened by the technical experience heterogeneity of researchers but weakened by repeated collaboration among researchers. Our analyses on the top 25 multinational pharmaceutical companies and their 59,998 patents registered from 1981 to 2012 provide strong support for our hypotheses. When geographic diversity is relatively low, teams with different levels of technical experience and more fresh collaborators improve performance by amplifying the benefits of sourcing diverse knowledge. With high geographic dispersion, on the other hand, minimal experience heterogeneity and more instances of past collaboration lead to better performance by facilitating the integration of diverse knowledge. The results shed light on the importance of technical and social relationships among researchers in sourcing and integrating location-specific knowledge and ultimately enhancing team performance.
Keywords: cross-border R&D collaboration; global innovation; multinational corporations; team composition; group learning theory; pharmaceutical industry (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (14)
Downloads: (external link)
http://link.springer.com/10.1057/s41267-020-00331-z Abstract (text/html)
Access to full text is restricted to subscribers.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:pal:jintbs:v:51:y:2020:i:5:d:10.1057_s41267-020-00331-z
Ordering information: This journal article can be ordered from
http://www.springer. ... nt/journal/41267/PS2
DOI: 10.1057/s41267-020-00331-z
Access Statistics for this article
Journal of International Business Studies is currently edited by John Cantwell
More articles in Journal of International Business Studies from Palgrave Macmillan, Academy of International Business
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().